Supplementary Materials

This PDF file includes:

  • Fig. S1. Tumor burden remains low with extended loss of DHHC20.
  • Fig. S2. pCREator (EGFR)-Cre expresses EGFR mutants equivalently in KPY mice.
  • Fig. S3. Myc mRNA levels increase upon inhibition of DHHC20.
  • Fig. S4. Presence of mutant KRAS is required to reduce cell growth from loss of EGFR palmitoylation.
  • Fig. S5. Inhibition of DHHC20 in H23 cells induces sensitivity to PI3K inhibitor.
  • Fig. S6. Low levels of DHHC20 correlate with better survival probability in patients.

[Download PDF]